It is possible, therefore, that the asparagine deamidation reaction (which may occur in low but significant amounts in vitro, during NGR-TNF production and storage, and in vivo, after drug injection in patients) may lead to a dual mechanism of tumor vessel targeting based on CD13 and αvβ3 recognition. Here, TNF is linked to neoplasm.